These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 16129066)
21. Molecular pathways in myelodysplastic syndromes and acute myeloid leukemia: relationships and distinctions-a review. Bernasconi P Br J Haematol; 2008 Sep; 142(5):695-708. PubMed ID: 18540941 [TBL] [Abstract][Full Text] [Related]
22. Clinical and cytogenetic findings of myelodysplastic syndromes showing hypocellular bone marrow or minimal dysplasia, in comparison with typical myelodysplastic syndromes. Toyama K; Ohyashiki K; Yoshida Y; Abe T; Asano S; Hirai H; Hirashima K; Hotta T; Kuramoto A; Kuriya S Int J Hematol; 1993 Aug; 58(1-2):53-61. PubMed ID: 8219112 [TBL] [Abstract][Full Text] [Related]
23. Classification and scoring systems in myelodysplastic syndromes: a retrospective analysis of 311 patients. Navarro I; Ruiz MA; Cabello A; Collado R; Ferrer R; Hueso J; Martinez J; Miguel A; Orero MT; Pérez P; Nolasco A; Carbonell F Leuk Res; 2006 Aug; 30(8):971-7. PubMed ID: 16423393 [TBL] [Abstract][Full Text] [Related]
24. [Myelodysplastic syndromes]. Garandeau C; Pautas E; Andreux M; Andreux J; Gaussem P; Siguret V Ann Biol Clin (Paris); 2000; 58(4):405-16. PubMed ID: 10932040 [TBL] [Abstract][Full Text] [Related]
25. The presence of clonal cell subpopulations in peripheral blood and bone marrow of patients with refractory cytopenia with multilineage dysplasia but not in patients with refractory anemia may reflect a multistep pathogenesis of myelodysplasia. Cermák J; Belicková M; Krejcová H; Michalová K; Zilovcová S; Zemanová Z; Brezinová J; Sieglová Z Leuk Res; 2005 Apr; 29(4):371-9. PubMed ID: 15725470 [TBL] [Abstract][Full Text] [Related]
26. [Re-evaluation of classification of myelodysplastic syndromes with low percentage bone marrow blasts]. Yu MH; Xu ZF; Li L; Nie L; Liu L; Zhang Y; Qin TJ; Hao YS; Xiao ZJ Zhonghua Xue Ye Xue Za Zhi; 2009 Jan; 30(1):3-7. PubMed ID: 19563026 [TBL] [Abstract][Full Text] [Related]
27. Aberrant promoter methylation of Dab2 gene in myelodysplastic syndrome. Yang Y; Zhang Q; Xu F; Chang C; Li X Eur J Haematol; 2012 Dec; 89(6):469-77. PubMed ID: 23005040 [TBL] [Abstract][Full Text] [Related]
28. The emergence of a C/EBPalpha mutation in the clonal evolution of MDS towards secondary AML. Kaeferstein A; Krug U; Tiesmeier J; Aivado M; Faulhaber M; Stadler M; Krauter J; Germing U; Hofmann WK; Koeffler HP; Ganser A; Verbeek W Leukemia; 2003 Feb; 17(2):343-9. PubMed ID: 12592334 [TBL] [Abstract][Full Text] [Related]
29. The molecular basis and clinical significance of genetic mutations identified in myelodysplastic syndromes. Zhang L; Padron E; Lancet J Leuk Res; 2015 Jan; 39(1):6-17. PubMed ID: 25465125 [TBL] [Abstract][Full Text] [Related]
30. [Pathogenesis of myelodysplastic syndromes by excessive mitochondrial fragmentation]. Hayashi Y Rinsho Ketsueki; 2024; 65(4):249-254. PubMed ID: 38684435 [TBL] [Abstract][Full Text] [Related]
31. Clinical response of myelodysplastic syndromes patients to treatment with coenzyme Q10. Galili N; Sechman EV; Cerny J; Mehdi M; Mumtaz M; Westervelt P; Maguire J; Raza A Leuk Res; 2007 Jan; 31(1):19-26. PubMed ID: 17064768 [TBL] [Abstract][Full Text] [Related]
32. [Alteration of methylation status of fragile histidine triad gene promoter in patients with myelodysplastic syndrome]. Yao DM; Qian J; Xu WR; Lin J; Jiang YW; Fei X; Han LX; Wang Y; Cen JN; Chen ZX Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Feb; 25(1):36-9. PubMed ID: 18247301 [TBL] [Abstract][Full Text] [Related]
33. [Research progress in molecular biology of pediatric myelodysplastic syndrome]. Ren YY; Zhu XF Zhongguo Dang Dai Er Ke Za Zhi; 2014 Sep; 16(9):957-61. PubMed ID: 25229970 [TBL] [Abstract][Full Text] [Related]
34. Molecular bases of myelodysplastic syndromes: lessons from animal models. Komeno Y; Kitaura J; Kitamura T J Cell Physiol; 2009 Jun; 219(3):529-34. PubMed ID: 19259975 [TBL] [Abstract][Full Text] [Related]
35. The genetic basis of phenotypic heterogeneity in myelodysplastic syndromes. Raza A; Galili N Nat Rev Cancer; 2012 Dec; 12(12):849-59. PubMed ID: 23175121 [TBL] [Abstract][Full Text] [Related]
36. A retrospective analysis of myelodysplastic syndromes with thrombocytosis: reclassification of the cases by WHO proposals. Cabello AI; Collado R; Ruiz MA; Martínez J; Navarro I; Ferrer R; Sosa AM; Carbonell F Leuk Res; 2005 Apr; 29(4):365-70. PubMed ID: 15725469 [TBL] [Abstract][Full Text] [Related]
37. Clinical implications of chromosomal abnormalities in 401 patients with myelodysplastic syndromes: a multicentric study in Japan. Toyama K; Ohyashiki K; Yoshida Y; Abe T; Asano S; Hirai H; Hirashima K; Hotta T; Kuramoto A; Kuriya S Leukemia; 1993 Apr; 7(4):499-508. PubMed ID: 8464227 [TBL] [Abstract][Full Text] [Related]
38. Recent advances in the understanding of iron overload in sideroblastic myelodysplastic syndrome. Cuijpers ML; Raymakers RA; Mackenzie MA; de Witte TJ; Swinkels DW Br J Haematol; 2010 May; 149(3):322-33. PubMed ID: 20067561 [TBL] [Abstract][Full Text] [Related]
39. [Progress of experimental study on myelodysplastic syndrome -- review]. Chen BA; Ding J; Xia GH Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Jun; 17(3):826-30. PubMed ID: 19549417 [TBL] [Abstract][Full Text] [Related]
40. Cytogenetic evolution following the transformation of myelodysplastic syndrome to acute myelogenous leukemia: implications on the overlap between the two diseases. Ghaddar HM; Stass SA; Pierce S; Estey EH Leukemia; 1994 Oct; 8(10):1649-53. PubMed ID: 7934160 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]